Oppenheimer Asset Management Inc. Sells 823 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Oppenheimer Asset Management Inc. lowered its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 4.9% during the fourth quarter, Holdings Channel reports. The institutional investor owned 16,096 shares of the medical device company’s stock after selling 823 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Cooper Companies were worth $1,480,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the stock. Victory Capital Management Inc. boosted its holdings in shares of Cooper Companies by 23.0% during the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after acquiring an additional 737,726 shares during the period. JPMorgan Chase & Co. lifted its holdings in Cooper Companies by 13.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock worth $543,979,000 after purchasing an additional 573,908 shares during the last quarter. Swedbank AB boosted its stake in Cooper Companies by 14.0% in the 4th quarter. Swedbank AB now owns 1,629,602 shares of the medical device company’s stock valued at $149,809,000 after purchasing an additional 200,000 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Cooper Companies by 11.9% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company’s stock valued at $200,665,000 after buying an additional 194,118 shares in the last quarter. Finally, Soros Fund Management LLC bought a new position in Cooper Companies during the 3rd quarter worth $19,310,000. 24.39% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on COO. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Wells Fargo & Company raised their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Morgan Stanley cut their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Finally, Citigroup reduced their price target on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research report on Friday, December 6th. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $117.22.

Cooper Companies Trading Up 1.4 %

Shares of COO opened at $91.65 on Tuesday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The Cooper Companies, Inc. has a 52-week low of $84.76 and a 52-week high of $112.38. The firm has a market cap of $18.29 billion, a price-to-earnings ratio of 47.00, a PEG ratio of 2.25 and a beta of 1.00. The business’s fifty day moving average is $92.63 and its 200-day moving average is $99.59.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. During the same quarter in the prior year, the business earned $0.87 earnings per share. The business’s revenue for the quarter was up 9.8% compared to the same quarter last year. Equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.